A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors

Background: Anti-hyperglycemic drug dipeptidyl peptidase-IV inhibitors (DPP-4i) have recently been recognized as bullous pemphigoid (BP) inducing drugs. It remains uncertain whether DPP-4i induce BP-IgG autoantibodies before the onset of BP. Objective: To evaluate the effect of DPP-4i in the develop...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Immunol
Главные авторы: Izumi, Kentaro, Nishie, Wataru, Beniko, Mutsuo, Shimizu, Hiroshi
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2019
Предметы:
Immunology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607930/
https://ncbi.nlm.nih.gov/pubmed/31297116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01439
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы